nivalin 10 mg tabletes
sopharma ad, bulgaria - galantamīna hidrobromīds - tablete - 10 mg
nivalin 5 mg tabletes
sopharma ad, bulgaria - galantamīna hidrobromīds - tablete - 5 mg
coldrin apvalkotās tabletes
elvim, sia, latvia - kofeīns, phenylephrini hydrochloridum, chlorphenamini maleas, paracetamolum - apvalkotā tablete
vancomycin sandoz 1000 mg pulveris infūziju šķīduma pagatavošanai
sandoz d.d., slovenia - vankomicīns - pulveris infūziju šķīduma pagatavošanai - 1000 mg
nivalin 5 mg/ml šķīdums injekcijām
sopharma ad, bulgaria - galantamīna hidrobromīds - Šķīdums injekcijām - 5 mg/ml
nivalin 2,5 mg/ml šķīdums injekcijām
sopharma ad, bulgaria - galantamīna hidrobromīds - Šķīdums injekcijām - 2,5 mg/ml
potassium chloride kabi 150 mg/ml koncentrāts infūziju šķīduma pagatavošanai
fresenius kabi polska sp.z o.o., poland - kalii chloridum - koncentrāts infūziju šķīduma pagatavošanai - 150 mg/ml
gentamicin krka 80 mg/2 ml šķīdums injekcijām/infūzijām
krka, d.d., novo mesto, slovenia - gentamicīns - Šķīdums injekcijām/infūzijām - 80 mg/2 ml
neopen suspensija injekcijām
intervet international b.v., nīderlande - neomicīna sulfāts, prokaīna benzilpenicilīns - suspensija injekcijām - aitas; cūkas; kaķi; liellopi; suņi; zirgi
celdoxome pegylated liposomal
yes pharmaceutical development services gmbh - doksorubicīna hidrohlorīds - breast neoplasms; ovarian neoplasms; multiple myeloma; sarcoma, kaposi - antineoplastiski līdzekļi - celdoxome pegylated liposomal is indicated in adults:as monotherapy for patients with metastatic breast cancer, where there is an increased cardiac risk. or treatment of advanced ovarian cancer in women who have failed a first-line platinum-based chemotherapy regimen. in combination with bortezomib for the treatment of progressive multiple myeloma in patients who have received at least one prior therapy and who have already undergone or are unsuitable for bone marrow transplant. for treatment of aids-related kaposi’s sarcoma (ks) in patients with low cd4 counts (< 200 cd4 lymphocytes/mm3) and extensive mucocutaneous or visceral disease. celdoxome pegylated liposomal may be used as first-line systemic chemotherapy, or as second line chemotherapy in aids-ks patients with disease that has progressed with, or in patients intolerant to, prior combination systemic chemotherapy comprising at least two of the following agents: a vinca alkaloid, bleomycin and standard doxorubicin (or other anthracycline).